open access
Cardiac implantable electronic device procedure history as the most important predictor of poor 2-year survival after transcatheter aortic valve replacement
Affiliations- 2nd Department of Cardiology, Central University Hospital, Medical University of Lodz, Łódź, Poland
open access
Abstract
Abstract
Supp./Additional Files (1)
About this articleTitle
Cardiac implantable electronic device procedure history as the most important predictor of poor 2-year survival after transcatheter aortic valve replacement
Journal
Kardiologia Polska (Polish Heart Journal)
Issue
Article type
Short communication
Published online
2023-03-05
Page views
22
Article views/downloads
23
DOI
10.33963/KP.a2023.0058
Pubmed
Authors
Michał Stegienta
Anita Korczak
Izabela Adamowicz
Anna Ceranka
Milena Jakuszczonek
Andrzej Walczak
Michał Krejca
Aleksandra Ryk
Jacek Burzyński
Jarosław Drożdż
References (9)- Wu C, Vasseur B, Maisel W. The March of Transcatheter Aortic Valve Replacement Therapy-US Food and Drug Administration Perspectives on Device Approval for Patients at Low Surgical Risk. JAMA Cardiol. 2020; 5(1): 5–6.
- Baumgartner H, Falk V, Bax JJ, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017; 38(36): 2739–2791.
- Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2022; 43(7): 561–632.
- Carroll JD, Mack MJ, Vemulapalli S, et al. STS-ACC TVT Registry of Transcatheter Aortic Valve Replacement. J Am Coll Cardiol. 2020; 76(21): 2492–2516.
- Gelves-Meza J, Lang RM, Valderrama-Achury MD, et al. Tricuspid Regurgitation Related to Cardiac Implantable Electronic Devices: An Integrative Review. J Am Soc Echocardiogr. 2022; 35(11): 1107–1122.
- Takagi H, Hari Y, Kawai N, et al. Impact of concurrent tricuspid regurgitation on mortality after transcatheter aortic-valve implantation. Catheter Cardiovasc Interv. 2019; 93(5): 946–953.
- Furer A, Chen S, Redfors B, et al. Effect of Baseline Left Ventricular Ejection Fraction on 2-Year Outcomes After Transcatheter Aortic Valve Replacement: Analysis of the PARTNER 2 Trials. Circ Heart Fail. 2019; 12(8): e005809.
- Crestanello JA, Popma JJ, Adams DH, et al. Long-Term Health Benefit of Transcatheter Aortic Valve Replacement in Patients With Chronic Lung Disease. JACC Cardiovasc Interv. 2017; 10(22): 2283–2293.
- Marzec K, Jaworska-Wilczyńska M, Kowalik I, et al. Comparison of long-term outcomes and risk factors of aortic stenosis treatment in patients undergoing transcatheter aortic valve implantation and surgical aortic valve replacement. Kardiol Pol. 2022; 80(7-8): 792–798.
